Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03448328 · ClinicalTrials.gov registry record · NA
Pea Protein Supplementation and Muscle Damage
A NA study, sponsored by Appalachian State University.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT03448328: Completed NA study, sponsored by Appalachian State University.
NCT03448328 is a NA study that has completed, run by Appalachian State University. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03448328, a NA study, has completed, sponsored by Appalachian State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if supplementation with NUTRALYS pea protein isolate compared to whey protein and apple juice (carbohydrate, non-protein control) before, during, and after a 90-minute bout of eccentric exercise can attenuate exercise-induced muscle damage, inflammation, and delayed onset of muscle soreness (DOMS), and speed recovery of muscle function.
Primary Outcome
Muscle damage marker
Interventions
- DIETARY_SUPPLEMENT Whey Protein
- DIETARY_SUPPLEMENT NUTRALYS pea protein supplement
- DIETARY_SUPPLEMENT Apple juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2018-03-05 |
| Est. Completion | 2020-06-01 |
| Phase | NA |
What the finished NCT03448328 record still lists
NCT03448328 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Whey Protein is the first listed.
NCT03448328 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03448328 about?
NCT03448328 is a clinical study titled "Pea Protein Supplementation and Muscle Damage". The purpose of this study is to determine if supplementation with NUTRALYS pea protein isolate compared to whey protein and apple juice (carbohydrate, non-protein control) before, during, and after a 90-minute bout of eccentric exercise can attenuate exercise-induced muscle damage, inflammation, and...
What is the current status of trial NCT03448328?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2018-03-05. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT03448328?
The interventions under investigation include: Whey Protein (DIETARY_SUPPLEMENT), NUTRALYS pea protein supplement (DIETARY_SUPPLEMENT), Apple juice (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03448328?
This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03448328's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI